VBI Vaccines (VBIV)
(Delayed Data from NSDQ)
$0.60 USD
+0.01 (1.59%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $0.58 -0.02 (-3.24%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/20/24 |
---|---|
Current Quarter | -0.53 |
EPS Last Quarter | NA |
Last EPS Surprise | NA |
ABR | 1.50 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.39 |
Next Year | -0.51 |
EPS (TTM) | -7.38 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.85M | 3.19M | 14.48M | 34.12M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 2.85M | 3.19M | 14.48M | 34.12M |
Low Estimate | 2.85M | 3.19M | 14.48M | 34.12M |
Year ago Sales | 0.49M | 0.72M | 8.68M | 14.48M |
Year over Year Growth Est. | 481.63% | 343.06% | 66.78% | 135.64% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.53 | -0.47 | -1.39 | -0.51 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.53 | -0.47 | -1.39 | -0.51 |
High Estimate | -0.53 | -0.47 | -1.39 | -0.51 |
Low Estimate | -0.53 | -0.47 | -1.39 | -0.51 |
Year ago EPS | -2.43 | -2.17 | -3.96 | -1.39 |
Year over Year Growth Est. | 78.19% | 78.34% | 64.90% | 63.31% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 0 | 0 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.53 | -0.47 | -1.39 | -0.51 |
7 Days Ago | -0.53 | -0.47 | -1.39 | -0.51 |
30 Days Ago | -0.17 | -0.16 | -0.82 | -2.38 |
60 Days Ago | -0.17 | -0.16 | -0.82 | -2.38 |
90 Days Ago | -0.17 | -0.16 | -0.82 | -2.38 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.53 | -0.47 | -1.39 | -0.51 |
Zacks Consensus Estimate | -0.53 | -0.47 | -1.39 | -0.51 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | NA | -0.38 | -2.17 | -2.43 | NA |
Estimate | NA | -0.14 | -2.16 | -2.27 | NA |
Difference | NA | -0.24 | -0.01 | -0.16 | -0.14 |
Surprise | NA | -171.43% | -0.46% | -7.05% | -59.65% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more